Compare SHASUN PHARMA with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ORCHID PHARMA LTD SHASUN PHARMA/
ORCHID PHARMA LTD
 
P/E (TTM) x 123.9 -0.5 - View Chart
P/BV x 8.5 0.1 7,244.6% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHASUN PHARMA   ORCHID PHARMA LTD
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ORCHID PHARMA LTD
Sep-13
SHASUN PHARMA/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs94194 48.6%   
Low Rs4635 130.3%   
Sales per share (Unadj.) Rs214.2276.5 77.5%  
Earnings per share (Unadj.) Rs5.3-79.2 -6.7%  
Cash flow per share (Unadj.) Rs15.8-43.5 -36.4%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.353.9 98.9%  
Shares outstanding (eoy) m56.6270.45 80.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.30.4 78.8%   
Avg P/E ratio x13.1-1.4 -906.2%  
P/CF ratio (eoy) x4.4-2.6 -167.7%  
Price / Book Value ratio x1.32.1 61.7%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9588,067 49.1%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2,1642,527 85.6%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m12,12719,477 62.3%  
Other income Rs m229407 56.3%   
Total revenues Rs m12,35619,884 62.1%   
Gross profit Rs m1,0091,103 91.5%  
Depreciation Rs m5942,519 23.6%   
Interest Rs m4155,227 7.9%   
Profit before tax Rs m230-6,236 -3.7%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m-73-125 58.1%   
Profit after tax Rs m302-5,580 -5.4%  
Gross profit margin %8.35.7 147.0%  
Effective tax rate %-31.72.0 -1,576.9%   
Net profit margin %2.5-28.7 -8.7%  
BALANCE SHEET DATA
Current assets Rs m6,88411,014 62.5%   
Current liabilities Rs m8,45632,060 26.4%   
Net working cap to sales %-13.0-108.1 12.0%  
Current ratio x0.80.3 237.0%  
Inventory Days Days6295 65.0%  
Debtors Days Days10834 320.5%  
Net fixed assets Rs m4,97029,440 16.9%   
Share capital Rs m113705 16.1%   
"Free" reserves Rs m2,8752,043 140.7%   
Net worth Rs m3,0203,800 79.5%   
Long term debt Rs m1,8179,018 20.2%   
Total assets Rs m13,34746,510 28.7%  
Interest coverage x1.6-0.2 -804.3%   
Debt to equity ratio x0.62.4 25.4%  
Sales to assets ratio x0.90.4 217.0%   
Return on assets %5.4-0.8 -707.0%  
Return on equity %10.0-146.9 -6.8%  
Return on capital %13.3-3.7 -356.7%  
Exports to sales %46.437.9 122.4%   
Imports to sales %14.222.6 63.0%   
Exports (fob) Rs m5,6227,378 76.2%   
Imports (cif) Rs m1,7284,406 39.2%   
Fx inflow Rs m5,8437,513 77.8%   
Fx outflow Rs m2,1735,649 38.5%   
Net fx Rs m3,6691,865 196.8%   
CASH FLOW
From Operations Rs m3981,682 23.6%  
From Investments Rs m-1,635-9,860 16.6%  
From Financial Activity Rs m1,3096,644 19.7%  
Net Cashflow Rs m71-1,535 -4.6%  

Share Holding

Indian Promoters % 39.2 32.3 121.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 4.6 78.3%  
FIIs % 17.6 3.3 533.3%  
ADR/GDR % 0.0 4.6 -  
Free float % 39.6 55.3 71.6%  
Shareholders   20,750 84,811 24.5%  
Pledged promoter(s) holding % 12.3 54.9 22.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   WOCKHARDT  J.B.CHEMICALS  DR. REDDYS LAB  BIOCON   FULFORD INDIA  

Compare SHASUN PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - PANACEA BIOTECH COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS